Study: Bone drug lowers breast cancer risk 38% in high-risk women

Title: Study: Bone drug lowers breast cancer risk 38% in high-risk women
Summary:Raloxifene, also known as Evista, is shown to reduce the risk of breast cancer without the side effects of Tamoxifen.
Published on : Mon Apr 19 18:10:15 2010 GMT

Source:Continue reading here…
Courtesy:USA Today

Related posts

• Understanding Lung Cancer (0)
• Types of Mesothelioma (0)
• Treatment Options For Mesothelioma (0)
• Treatment Options For Mesothelioma (0)
• Things You Can Do to Prevent Mesothelioma and Asbestos Cancer (0)
• Things You Can Do to Prevent Mesothelioma and Asbestos Cancer (0)
• The Symptoms of Pleural Mesothelioma (0)
• Symptoms of Pleural Mesothelioma (0)

This entry was posted on Monday, April 19th, 2010 at 1:04 pm and is filed under Breast Cancer News, News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.